Trial Details
UNKNOWNBasic Information
| Clinical ID | c3598 |
|---|---|
| Identifier | NCT01803724 |
| Trial Title | Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | - |
Participant Information
| Sponsor | Pontificia Universidad Catolica de Chile |
|---|---|
| City | Metropolitan |
| Country/Region | Chile |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2013-05 |
|---|---|
| Primary Completion Date | 2014-06 |
| Completion Date | 2014-12 |